$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods and products for nucleic acid delivery 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-047/40
출원번호 US-0675523 (1996-07-03)
발명자 / 주소
  • Isner Jeffrey M. (Weston MA)
출원인 / 주소
  • St. Elizabeth\s Medical Center of Boston, Inc. (Boston MA 02)
인용정보 피인용 횟수 : 76  인용 특허 : 4

초록

The present invention provides a method for the delivery of a nucleic acid to an arterial cell comprising contacting the cell with a hydrophilic polymer incorporating the nucleic acid. The nucleic acid may be any nucleic acid, including antisense DNA or RNA. The nucleic acid may encode hormones, enz

대표청구항

A method for inducing the formation of new blood vessels in a desired target tissue in a human host, comprising contacting an arterial cell in an artery or blood vessel via a balloon catheter coated with a hydrogel polymer admixed with a first DNA encoding an angiogenic protein selected from the gro

이 특허에 인용된 특허 (4)

  1. Sahatjian Ronald (Lexington MA), Drug delivery system making use of a hydrogel polymer coating.
  2. Fan You-Ling (East Brunswick NJ), Hydrophilic lubricious coatings.
  3. Srivastava Arun (Indianapolis IN), Safe vector for gene therapy.
  4. Nabel Elizabeth G. (Ann Arbor MI) Nabel Gary J. (Ann Arbor MI), Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor.

이 특허를 인용한 특허 (76)

  1. Crystal Ronald G. ; Magovern Christopher J., Adenoviral-mediated gene transfer to adipocytes.
  2. Nakamura, Toshikazu; Funakoshi, Hiroshi; Miyazawa, Daisuke; Iwatani, Kunio, Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof.
  3. Ferrara Napoleone ; Isner Jeffrey M. ; Schwall Ralph H., Angiogenesis using hepatocyte growth factor.
  4. Parker Theodore L. ; Joslyn Danforth ; Nikolic Serjan D., Angiogenic implant delivery system and method.
  5. Rosen,Craig A.; Hu,Jing Shan; Cao,Liang, Antibodies to human vascular endothelial growth factor 2.
  6. Rosen, Craig A.; Hu, Jing Shan; Cao, Liang, Antibodies to human vascular endothelial growth factor 2 and methods of using the same.
  7. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Antibodies to vascular endothelial growth factor 2 and methods of using same.
  8. Mueller, Richard, Apparatus and method for delivering therapeutic and diagnostic agents.
  9. Mueller,Richard, Apparatus and method for delivering therapeutic and diagnostic agents.
  10. Haim, Shlomo Ben; Yaron, Uri; Matcovitch, Avraham, Apparatus and method for intracardiac therapy using sensor for heart wall thickness.
  11. Oron,Uri; Matcovitch,Avraham, Apparatus for providing electromagnetic biostimulation of tissue using optics and echo imaging.
  12. Barry, James; Palasis, Maria; Ellis, Louis; Mickley, Timothy; Berg, Brian, Biocompatible medical devices.
  13. Kiser, Patrick F.; Thomas, Allen A., Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments.
  14. Laughlin,Mary J.; Haynesworth,Stephen; Pompili,Vincent, Cell-based therapies for ischemia.
  15. Nabel,Gary J.; Yang,Zhi yong; Nabel,Elizabeth G., Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21.
  16. Li, Weiping; Mao, Hai-Quan; Leong, Kam W., Controlled delivery of therapeutic agents by insertable medical devices.
  17. Chee, U. Hiram; Meuller, Richard, Devices and methods for delivering a drug.
  18. Wolff, Jon A.; Duke, David J.; Felgner, Philip L., Expression of exogenous polynucleotide sequences in a vertebrate.
  19. Andrew Baird ; Grai Andreason, Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF.
  20. John H. Lawrence, III ; J. Kevin Donahue, Gene delivery compositions and methods.
  21. Lawrence, III,John H.; Donahue,J. Kevin, Gene delivery compositions and methods.
  22. Hammond H. Kirk ; Giordano Frank J. ; Dillmann Wolfgang H., Gene therapies for enhancing cardiac function.
  23. Hammond H. Kirk ; Giordano Frank J. ; Dillmann Wolfgang H., Gene therapies for enhancing cardiac function.
  24. Morishita,Ryuichi; Taniyama,Yoshiaki; Ogihara,Toshio, Gene therapy for cardiomyopathy.
  25. Morishita, Ryuichi; Ogihara, Toshio, Gene therapy for cerebrovascular disorders.
  26. Maria Palasis ; Kenneth Walsh, High efficiency local drug delivery.
  27. Kim, Jong-Mook; Hahn, Woong, Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor.
  28. Kim, Jong-Mook; Hahn, Woong, Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor.
  29. Kim, Jong-Mook; Hahn, Woong; Park, Eun-Jin, Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor.
  30. Forman, Michael Robert; Bobo, Jr., Donald E., Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis.
  31. Haim Shlomo Ben,ILX ; Yaron Uri,ILX ; Matcovitch Avraham,ILX, Intracardiac drug delivery.
  32. Haim Shlomo Ben,ILX ; Yaron Uri,ILX ; Matcovitch Avraham,ILX, Intracardiac drug delivery device utilizing spring-loaded mechanism.
  33. Kaplan Aaron V. ; Simons Michael, Localized intravascular delivery of growth factors for promotion of angiogenesis.
  34. Morishita Ryuichi,JPX ; Ogihara Toshio,JPX ; Nakamura Toshikazu,JPX ; Tomita Tetsuya,JPX ; Ochi Takahiro,JPX, Medicament comprising HGF gene.
  35. Morishita,Ryuichi; Ogihara,Toshio; Nakamura,Toshikazu; Tomita,Tetsuya; Ochi,Takahiro, Medicament comprising HGF gene.
  36. Chee,U. Hiram; Mueller,Richard L.; Kermode,James R.; Tom,Curtis P.; Murphy Chutorian,Douglas, Method and apparatus for treatment of atrial fibrillation.
  37. Lee, Myoung Woo; Kim, Young Jin; Choi, Jeong Eun; Yang, Mal Sook; Moon, Young Joon; Kim, Sun Kyung; Kim, Hugh Chul; Park, Joon Seong; Jang, In Keun, Method for isolating and culturing multipotent progenitor cells from umbilical cord blood.
  38. Ben-Haim, Shlomo; Fenster, Maier, Method for treating tissue through injection of a therapeutic agent.
  39. Parker Theodore L. ; Joslyn Danforth ; Nikolic Serjan D., Method of enhancing blood flow in tissue.
  40. Crystal, Ronald G.; Hidaka, Chisa; Boachie-Adjei, Oheneba; Rawlins, Bernard A.; Kovesdi, Imre, Method of enhancing bone density.
  41. Elia, James P., Method of growing an artery.
  42. Uri Oron IL; Avraham Matcovitch IL, Method of treating a heart using cells irradiated in vitro with biostimulatory irradiation.
  43. Nakamura Toshikazu,JPX ; Komamura Kazuo,JPX ; Miyatake Kunio,JPX, Method of treating dilated cardiomyopathy.
  44. Bunting Stuart ; Gold Herman K. ; Leinbach Robert C. ; Schwall Ralph H., Methods and compositions for treating vascular stenosis.
  45. Isner Jeffrey M. ; Asahara Takayuki, Methods for enhancing angiogenesis with endothelial progenitor cells.
  46. Dzau, Victor J.; Pratt, Richard E.; Mann, Michael J.; Ehsan, Afshin; Griese, Daniel P., Methods for implanting cells.
  47. Victor J. Dzau ; Richard E. Pratt ; Michael J. Mann ; Afshin Ehsan ; Daniel P. Griese, Methods for implanting cells.
  48. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2.
  49. Alderson, Ralph; Melder, Robert; Roschke, Viktor; Ruben, Steven M.; Rosen, Craig A., Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies.
  50. Chee, U. Hiram; Mueller, Richard L.; Kermode, James R.; Tom, Curtis P.; Murphy-Chutorian, Douglas, Methods of treating cardiac arrhythmia.
  51. Forman, Michael Robert, Multi-balloon drug delivery catheter for angiogenesis.
  52. Forman,Michael Robert, Multi-balloon drug delivery catheter for angiogenesis.
  53. Rosen,Craig A.; Hu,Jing Shan; Cao,Liang, Polynucleotides encoding human vascular endothelial growth factor 2.
  54. Shi Rui-wen,CNX ; Gao Run-lin,CNX, Protein-coated medical substrates for local delivery of genes and method of forming coatings on the substrates.
  55. Rashtchian, Ayoub; Solus, Joseph, Stable compositions for nucleic acid amplification and sequencing.
  56. Wolff Jon A. ; Duke David J. ; Felgner Philip L., Stimulating vascular growth by administration of DNA sequences encoding VEGF.
  57. Roth, Laurence A.; Herman, Stephen Jack, Targeted delivery via biodegradable polymers.
  58. McBride,James F.; Gehrke,Stevin H.; Fisher,John P., Temperature controlled solute delivery system.
  59. Michal Eugene T. ; Buchko Christopher J. ; Bigus Stephen J., Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device.
  60. Fick James R., Tumor delivery vehicles.
  61. James R. Fick, Tumor delivery vehicles.
  62. Alitalo, Kari; Yl?-Herttuala, Seppo; Hiltunen, Mikko O.; Jeltsch, Markku M.; Achen, Marc G., Use of VEGF-C to prevent restenosis.
  63. Alitalo, Kari; Ylä-Herttuala, Seppo; Hiltunen, Mikko O.; Jeltsch, Markku M.; Achen, Marc G., Use of VEGF-D gene to prevent restenosis.
  64. Alderson,Ralph; Melder,Robert; Roschke,Viktor; Ruben,Steven M.; Rosen,Craig A., Use of vascular endothelial growth factor to treat photoreceptor cells.
  65. Neufeld Gera,ILX ; Keshet Eli,ILX ; Vlodavsky Israel,ILX ; Poltorak Zoya,ILX, VEGF.sub.145 expression vectors.
  66. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Vascular endothelial growth factor 2.
  67. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Vascular endothelial growth factor 2.
  68. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Vascular endothelial growth factor 2.
  69. Rosen, Craig A.; Albert, Vivian R.; Ruben, Steven M.; Wager, Ruth, Vascular endothelial growth factor 2.
  70. Rosen, Craig A.; Albert, Vivian R.; Ruben, Steven M.; Wager, Ruth E., Vascular endothelial growth factor 2.
  71. Rosen, Craig A.; Albert, Vivian R.; Ruben, Steven M.; Wager, Ruth E., Vascular endothelial growth factor 2.
  72. Rosen, Craig; Albert, Vivian; Ruben, Steven M.; Wager, Ruth, Vascular endothelial growth factor 2.
  73. Rosen, Craig; Albert, Vivian; Ruben, Steven M.; Wager, Ruth, Vascular endothelial growth factor 2.
  74. Rosen,Craig A.; Albert,Vivian R.; Ruben,Steven M.; Wager,Ruth E., Vascular endothelial growth factor 2.
  75. Hu,Jing Shan; Rosen,Craig A.; Cao,Liang, Vascular endothelial growth factor 2 and methods of use.
  76. Coleman,Timothy A., Vascular endothelial growth factor-2.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로